Westren Pharma Tranexamic Acid Injection Human Medicine for Injection

• Model NO.: injection
• Pharmaceutical Technology: Chemical Synthesis
• Dosage: 5ml
• Use: Injection
• Transport Package: Box
• Specification: 5ml
• Origin: China
• Production Capacity: 500000box/Month

Product Description

Product Name	Tramexamic acid injection
Contians	Tramexamic acid 250mg
Package	5ml*5amps/box
Store	Store at 20° to 25° C (68° to 77°F)
Shelf lift	36 Month
Apllication	Tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i.e., actions similar to aminocaproic acid. Tranexamic acid is about 10 times more potent in vitro than aminocaproic acid. Tranexamic acid binds more strongly than aminocaproic acid to both the strong and weak receptor sites of the plasminogen molecule in a ratio corresponding to the difference in potency between the compounds. Tranexamic acid in a concentration of 1 mg per mL does not aggregate platelets in vitro. Tranexamic acid in concentrations as low as 1 mg per mL can prolong the thrombin time. However, tranexamic acid in concentrations up to 10 mg per mL in blood showed no influence on the platelet count, the coagulation time, or other coagulation factors in whole blood or citrated blood from normal subjects.